{"id":"https://openalex.org/W2993434397","doi":null,"title":"EFFECT OF TOLL-LIKE RECEPTOR INHIBITOR IMIQUIMOD ON IL1R1 INTERACTION WITH IL-1RA AND ITS SNP VARIANT-AN IN SILICO APPROACH","display_name":"EFFECT OF TOLL-LIKE RECEPTOR INHIBITOR IMIQUIMOD ON IL1R1 INTERACTION WITH IL-1RA AND ITS SNP VARIANT-AN IN SILICO APPROACH","alternate_titles":[],"publication_year":2016,"publication_date":"2016-03-15","ids":{"openalex":"https://openalex.org/W2993434397","mag":"2993434397"},"language":"en","primary_location":{"id":"mag:2993434397","doi":null,"is_oa":true,"landing_page_url":"https://innovareacademics.in/journals/index.php/ijpps/article/view/10823","pdf_url":null,"source":{"id":"https://openalex.org/S2764469077","display_name":"International Journal of Pharmacy and Pharmaceutical Sciences","issn_l":"0975-1491","issn":["0975-1491","2656-0097"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmacy and Pharmaceutical Sciences","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2993434397"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://innovareacademics.in/journals/index.php/ijpps/article/view/10823","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000562638","display_name":"Anand Thiyagaraj","orcid":"https://orcid.org/0000-0002-1151-7828","observed_orcids":["https://orcid.org/0000-0002-1151-7828"]},"institutions":[{"id":"https://openalex.org/I4210131147","display_name":"SRM University","ror":"https://ror.org/037skf023","country_code":"IN","type":"education","lineage":["https://openalex.org/I145286018","https://openalex.org/I4210131147"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Anand Thiyagaraj","raw_affiliation_strings":["SRM UNIVERSITY,"],"raw_orcid":"https://orcid.org/0000-0002-1151-7828","affiliations":[{"raw_affiliation_string":"SRM UNIVERSITY,","institution_ids":["https://openalex.org/I4210131147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003777048","display_name":"Jithin S. Sunny","orcid":"https://orcid.org/0000-0002-8811-3565","observed_orcids":["https://orcid.org/0000-0002-8811-3565"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jithin S. Sunny","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8811-3565","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034306073","display_name":"Waheeta Hopper","orcid":"https://orcid.org/0000-0001-6912-4835","observed_orcids":["https://orcid.org/0000-0001-6912-4835"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Waheeta Hopper","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6912-4835","affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.415,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.51432501,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":96},"biblio":{"volume":"8","issue":"5","first_page":"109","last_page":"112"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.45559999346733093,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.45559999346733093,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.11760000139474869,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.07900000363588333,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imiquimod","display_name":"imiquimod","score":0.8759999871253967},{"id":"https://openalex.org/keywords/il-1r1","display_name":"IL1R1","score":0.8820000290870667},{"id":"https://openalex.org/keywords/interleukin-1-receptor-antagonist","display_name":"interleukin-1 receptor antagonist","score":0.9890000224113464},{"id":"https://openalex.org/keywords/single-nucleotide-polymorphisms","display_name":"single nucleotide polymorphisms","score":0.9919999837875366},{"id":"https://openalex.org/keywords/conformational-instability","display_name":"conformational instability","score":0.7860000133514404},{"id":"https://openalex.org/keywords/protein-protein-docking","display_name":"protein-protein docking","score":0.7590000033378601},{"id":"https://openalex.org/keywords/ligand-binding","display_name":"ligand binding","score":0.5630000233650208},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.7440000176429749},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C149892131","wikidata":"https://www.wikidata.org/wiki/Q14914156","display_name":"Interleukin 1 receptor antagonist","level":5,"score":0.7115185856819153},{"id":"https://openalex.org/C10775765","wikidata":"https://www.wikidata.org/wiki/Q21117797","display_name":"Interleukin 1 receptor, type I","level":4,"score":0.7111905813217163},{"id":"https://openalex.org/C119557319","wikidata":"https://www.wikidata.org/wiki/Q18032637","display_name":"Interleukin 1 receptor, type II","level":5,"score":0.6427804827690125},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.6359750032424927},{"id":"https://openalex.org/C139275648","wikidata":"https://www.wikidata.org/wiki/Q17134011","display_name":"SNP","level":5,"score":0.4723576009273529},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4692798852920532},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.421044260263443},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3561360836029053},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20811840891838074},{"id":"https://openalex.org/C75184817","wikidata":"https://www.wikidata.org/wiki/Q5381540","display_name":"Enzyme-linked receptor","level":3,"score":0.19700264930725098},{"id":"https://openalex.org/C153209595","wikidata":"https://www.wikidata.org/wiki/Q501128","display_name":"Single-nucleotide polymorphism","level":4,"score":0.1893254518508911},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.16091421246528625},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12031218409538269},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09342679381370544},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.09114524722099304},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.0},{"id":"https://openalex.org/C181901479","wikidata":"https://www.wikidata.org/wiki/Q14877650","display_name":"Interleukin 5","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2993434397","doi":null,"is_oa":true,"landing_page_url":"https://innovareacademics.in/journals/index.php/ijpps/article/view/10823","pdf_url":null,"source":{"id":"https://openalex.org/S2764469077","display_name":"International Journal of Pharmacy and Pharmaceutical Sciences","issn_l":"0975-1491","issn":["0975-1491","2656-0097"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmacy and Pharmaceutical Sciences","raw_type":null}],"best_oa_location":{"id":"mag:2993434397","doi":null,"is_oa":true,"landing_page_url":"https://innovareacademics.in/journals/index.php/ijpps/article/view/10823","pdf_url":null,"source":{"id":"https://openalex.org/S2764469077","display_name":"International Journal of Pharmacy and Pharmaceutical Sciences","issn_l":"0975-1491","issn":["0975-1491","2656-0097"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmacy and Pharmaceutical Sciences","raw_type":null},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1939997832","https://openalex.org/W1985588649","https://openalex.org/W2004188337","https://openalex.org/W2044913358","https://openalex.org/W2046440869","https://openalex.org/W2057704715","https://openalex.org/W2073598149","https://openalex.org/W2074438676","https://openalex.org/W2076918198","https://openalex.org/W2080382112","https://openalex.org/W2080404460","https://openalex.org/W2081912151","https://openalex.org/W2085701175","https://openalex.org/W2089002446","https://openalex.org/W2100988500","https://openalex.org/W2115871198","https://openalex.org/W2116101489","https://openalex.org/W2117047064","https://openalex.org/W2122732537","https://openalex.org/W2123693759","https://openalex.org/W2130479394","https://openalex.org/W2130606742","https://openalex.org/W2170421654"],"related_works":["https://openalex.org/W4229001489","https://openalex.org/W3108933992","https://openalex.org/W2514413001","https://openalex.org/W2038832085","https://openalex.org/W2076918198","https://openalex.org/W2418394173","https://openalex.org/W1634162230","https://openalex.org/W2063063022","https://openalex.org/W1973064016","https://openalex.org/W4280610468"],"abstract_inverted_index":{"Objective:":[0],"Interleukin":[2,12,69],"1":[3,13,70],"receptor":[4,71],"antagonist":[5,10],"(IL1Ra)":[6],"acts":[7],"as":[8,38],"an":[9,178,252],"to":[11,25,35,92,110,137,181],"beta":[14],"(IL1\u03b2)":[15],"signalling":[16],"in":[17,31,40,52,96,120,145,151,168,226],"maintaining":[18],"homeostasis.":[19],"A":[20,102],"loss":[21],"of":[22,68,177,188,246],"function":[23],"due":[24],"Single":[26],"Nucleotide":[27],"Polymorphism":[28],"(SNP)":[29],"occurrence":[30],"IL1Ra":[32,88,133,160],"can":[33],"lead":[34],"dysregulated":[36],"state":[37],"seen":[39,144],"autoimmune":[41],"disease":[42],"pathogenesis.":[43],"The":[44,149],"current":[45],"study":[46,93],"aims":[47],"at":[48],"achieving":[49],"conformational":[50,186,201,231,244],"stability":[51,187],"the":[53,61,65,94,97,100,111,118,146,152,157,166,182,185,189,243],"IL1R1-IL1Ra_SNP":[54,147,183,190,247],"complex":[55,113,191,248],"by":[56,234],"introducing":[57,251],"a":[58,195],"ligand":[59,180],"into":[60],"region":[62],"apart":[63,215],"from":[64,216],"active":[66,218],"site":[67],"type1":[72],"(IL1R1).":[73],"Methods:":[76],"Protein-protein":[78],"docking":[79,116,176],"was":[80,106,123,143,240],"performed":[81],"using":[82,108,114],"ClusPro,":[83],"for":[84,198,229],"IL1R1":[85,138,158,210],"with":[86,159],"IL1\u03b2,":[87,260],"and":[89,117,161,171],"IL1Ra_SNP":[90,162],"variant":[91,163],"difference":[95,150],"interaction":[98],"between":[99,156],"complexes.":[101],"known":[103],"inhibitor,":[104],"Imiquimod":[105],"docked":[107],"Glide,":[109],"Il1R1-IL1Ra_SNP":[112],"flexible":[115],"change":[119,167],"surface":[121],"energy":[122],"calculated.":[124],"Results:":[127],"Binding":[129],"Interactions":[130],"show":[131],"that":[132,242],"binds":[134],"more":[135],"avidly":[136],"than":[139],"IL1\u03b2.":[140],"Conformational":[141],"instability":[142,232,245],"complex.":[148],"amino":[153],"acid":[154],"interactions":[155],"further":[164],"illustrated":[165],"binding":[169,213],"residues":[170],"hydrogen":[172],"bond":[173],"formation.":[174],"Upon":[175],"appropriate":[179,253],"complex,":[184],"enhanced":[192],"considerably":[193],"suggesting":[194],"possible":[196],"mechanism":[197],"treating":[199],"SNP-induced":[200],"instability.":[202],"Conclusion:":[205],"Toll-like":[207],"receptors":[208],"like":[209],"have":[211,222],"many":[212],"pockets":[214],"its":[217],"site.":[219],"No":[220],"strategies":[221],"yet":[223],"been":[224],"reported":[225],"targeting":[227],"them":[228],"correcting":[230],"induced":[233],"SNP.":[235],"Through":[236],"our":[237],"study,":[238],"it":[239],"observed":[241],"decreased":[249],"upon":[250],"small":[254],"molecule.":[255],"Keywords:":[258],"IL1R1,":[261],"IL1Ra,":[262],"SNP":[263]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2993434397","counts_by_year":[{"year":2018,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2019-12-13T00:00:00"}
